{"id":"W4410811464","doi":"10.1200/jco.2025.43.16_suppl.5090","title":"8-year outcomes of enzalutamide (ENZA) versus a non-steroidal anti-androgen (NSAA) for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Alberta; University of British Columbia; Ottawa Hospital","funders":"Cancer Council Australia","keywords":"Enzalutamide; Medicine; Prostate cancer; Oncology; Internal medicine; Androgen; Hormone; Cancer; Gynecology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001328714,0.0003601414,0.0007674627,0.0002772501,0.0001462569,0.0003781508,0.0003346338,0.0004968648,0.0027399],"category_scores_gemma":[0.001214981,0.0001399723,0.001414233,0.0002236263,0.0002438686,0.0004995475,0.0003333846,0.001103359,0.0003049948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004672917,"about_ca_system_score_gemma":0.0004157216,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008166447,"about_ca_topic_score_gemma":0.001656221,"domain_scores_codex":[0.9995785,0.0001968194,0.00003521958,0.00005612187,0.00004758738,0.00008572928],"domain_scores_gemma":[0.9990363,0.000247281,0.0003327387,0.00004240542,0.00004306096,0.0002981903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8845811,0.009298743,0.04428496,0.0004208103,0.00220163,0.0001651375,0.0001075432,0.002820889,0.004224659,0.0001304228,0.001619625,0.05014447],"study_design_scores_gemma":[0.07375186,0.6320606,0.2802829,0.0001322869,0.003557911,0.0004371619,0.0001581574,0.003582491,0.002991505,0.000351772,0.002638499,0.00005483482],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972215,0.001212136,0.0001044972,0.00008542727,0.00003797499,0.000089434,0.0005557136,0.00000890569,0.0006844611],"genre_scores_gemma":[0.9976997,0.000354308,0.0001123268,0.0001017342,0.00004329779,0.0001183886,0.0008448196,0.000002964798,0.0007224075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0027399,"threshold_uncertainty_score":0.009165883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1383018353780085,"score_gpt":0.5165302946858149,"score_spread":0.3782284593078064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}